BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21625166)

  • 1. Stereotactic body radiation therapy for gastrointestinal malignancies.
    Minn AY; Koong AC; Chang DT
    Front Radiat Ther Oncol; 2011; 43():412-427. PubMed ID: 21625166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors.
    Barney BM; Olivier KR; Macdonald OK; Fong de Los Santos LE; Miller RC; Haddock MG
    Am J Clin Oncol; 2012 Dec; 35(6):537-42. PubMed ID: 21659830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of stereotactic body radiation therapy in gastrointestinal malignancies in locally advanced and metastatic settings.
    Khrizman P; Small W; Dawson L; Benson AB
    Clin Colorectal Cancer; 2010 Jul; 9(3):136-43. PubMed ID: 20643617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery.
    Mazzola R; Fersino S; Aiello D; Gregucci F; Tebano U; Corradini S; Di Paola G; Cirillo M; Tondulli L; Ruffo G; Ruggieri R; Alongi F
    Strahlenther Onkol; 2018 Sep; 194(9):835-842. PubMed ID: 29696321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-Fraction Stereotactic Body Radiation Therapy (SBRT) and Chemotherapy for the Local Management of Metastatic Pancreatic Cancer.
    Lischalk JW; Burke A; Chew J; Elledge C; Gurka M; Marshall J; Pishvaian M; Collins S; Unger K
    J Gastrointest Cancer; 2018 Jun; 49(2):116-123. PubMed ID: 28044263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Venkat PS; Hoffe SE; Frakes JM
    Cancer Control; 2017; 24(3):1073274817729259. PubMed ID: 28975831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiation therapy (SBRT) in pancreatic cancer: is it ready for prime time?
    Chang BW; Saif MW
    JOP; 2008 Nov; 9(6):676-82. PubMed ID: 18981547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiotherapy for unresectable pancreatic cancer.
    Chang ST; Goodman KA; Yang GP; Koong AC
    Front Radiat Ther Oncol; 2007; 40():386-394. PubMed ID: 17641521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiotherapy (SBRT) for patients with locally advanced pancreatic cancer: A single center experience.
    Jumeau R; Delouya G; Roberge D; Donath D; Béliveau-Nadeau D; Campeau MP
    Dig Liver Dis; 2018 Apr; 50(4):396-400. PubMed ID: 29326012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.
    Ahmed KA; Torres-Roca JF
    Cancer Control; 2016 Jan; 23(1):21-9. PubMed ID: 27009453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic radiotherapy in the liver hilum. Basis for future studies.
    Zamboglou C; Messmer MB; Becker G; Momm F
    Strahlenther Onkol; 2012 Jan; 188(1):35-41. PubMed ID: 22194027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma.
    Gkika E; Schultheiss M; Bettinger D; Maruschke L; Neeff HP; Schulenburg M; Adebahr S; Kirste S; Nestle U; Thimme R; Grosu AL; Brunner TB
    Radiat Oncol; 2017 Jul; 12(1):116. PubMed ID: 28701219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved radiotherapy for primary and secondary liver cancer: stereotactic body radiation therapy.
    Tao C; Yang LX
    Anticancer Res; 2012 Feb; 32(2):649-55. PubMed ID: 22287758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiation therapy: a comprehensive review.
    Chang BK; Timmerman RD
    Am J Clin Oncol; 2007 Dec; 30(6):637-44. PubMed ID: 18091059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiation therapy in multiple organ sites.
    Timmerman RD; Kavanagh BD; Cho LC; Papiez L; Xing L
    J Clin Oncol; 2007 Mar; 25(8):947-52. PubMed ID: 17350943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric evaluation of simultaneous integrated boost during stereotactic body radiation therapy for pancreatic cancer.
    Yang W; Reznik R; Fraass BA; Nissen N; Hendifar A; Wachsman A; Sandler H; Tuli R
    Med Dosim; 2015; 40(1):47-52. PubMed ID: 25445989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.
    Goodman KA; Wiegner EA; Maturen KE; Zhang Z; Mo Q; Yang G; Gibbs IC; Fisher GA; Koong AC
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):486-93. PubMed ID: 20350791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiation therapy for liver metastases.
    Dawood O; Mahadevan A; Goodman KA
    Eur J Cancer; 2009 Nov; 45(17):2947-59. PubMed ID: 19773153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiotherapy in the treatment of pancreatic cancer.
    Trakul N; Koong AC; Chang DT
    Semin Radiat Oncol; 2014 Apr; 24(2):140-7. PubMed ID: 24635871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.
    Gkika E; Adebahr S; Kirste S; Schimek-Jasch T; Wiehle R; Claus R; Wittel U; Nestle U; Baltas D; Grosu AL; Brunner TB
    Strahlenther Onkol; 2017 Jun; 193(6):433-443. PubMed ID: 28138949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.